COVID-19 vaccine study letter Mar 2021

For participants enrolled into the Novavax COVID-19 vaccine trial at our Trust

Dear Novavax Vaccine Trial Participant,

Thank you for continuing to send your swabs when you develop possible COVID-19 symptoms. 

In order to make sure your swabs are processed at the correct laboratories for the Novavax trial there is a minor change to the way you send your swabs. You will shortly be receiving an envelope from your trial site containing white Royal Mail stickers and instructions about how to apply these to your swab kits. Please start using these as soon as you receive them.

By doing this it will allow the continued processing of swabs by the same laboratories, ensuring testing consistency throughout the trial and also allows viral samples to be sequenced to look for mutant strains.

These envelopes have been packed by Royal Mail, but your name and address are applied by your trial site. Your personal details have not been shared. 

Please also contact your trial site if your postal address requires updating.

Please see further instructions below.

Subject instructions to relabel the existing PCR kits

  • Each subject will get one sealed envelope containing three new return labels and three purple kit stickers
  • Wash your hands with soap and warm water for 20 seconds.
  • Each time you do a testapply 1 white Royal Mail return label and 1 purple sticker on the return box
  • Stick 1 white Royal Mail return label on the return box. You must cover the old return label, if there’s already one there.
  • Stick 1 purple sticker onto any free space on the return box.
  • Once these new return labels are received confirm the acknowledgement back to sites
  • For more questions/concerns in this regard please reach out to your site staff and they should be able to help you in this regard.

Many thanks for your continued participation in the trial.

Clinical Research Team
St Stephen’s Centre
Chelsea and Westminster Hospital
07825 681 110

Contributors
George Vasilopoulos